Skip to main content

Advertisement

Log in

HPV vaccination uptake among foreign-born Blacks in the US: insights from the National Health Interview Survey 2013–2017

  • Original Paper
  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Abstract

Introduction

Human papillomavirus (HPV) vaccination uptake is lower among foreign-born than US-born individuals, but HPV-related (e.g., cervical) cancer risks are disproportionately higher among immigrant populations. Although timely vaccination can help reduce these risks, less is known about differences in the low HPV vaccination uptake among foreign-born groups, especially Black immigrants. The purpose of this study was to examine the differences in HPV vaccination initiation among US- and foreign-born Black men and women.

Method

Data from the 2013–2017 National Health Interview Survey on Black adults, aged 18–37 years, were analyzed in 2019. HPV vaccination initiation prevalence among US- and foreign-born blacks by region of birth were examined. Multivariate binary logistic regression analysis was used to examine the relationship between foreign-birth status and HPV vaccination initiation separately among men and women, after adjusting for sociodemographic and health-related factors.

Results

There were significant differences (p < 0.001) in HPV vaccination initiation among Blacks from the US (22.5%), Africa (14.2%), and Americas/Caribbean Islands (11.4%). Adjusted odds of HPV vaccination initiation were lower among foreign- than US-born Blacks (AOR 0.71, CI 0.52, 0.98) but insignificant after controlling for health-related factors. Being ≤ 17 years versus 18–26 years at age of vaccine eligibility (AOR 3.44, CI 2.90, 4.07) was associated with HPV vaccination, and this relationship remained significant among men and women. Being single was associated with vaccination initiation among men, and some college experience, fair/poor health, obstetric/gynecological visit, and pap test were associated with HPV vaccination. Conclusion Cancer prevention strategies to promote HPV vaccination should consider making age-appropriate, gender-specific, and culturally relevant programs among foreign-born blacks in the US. Health insurance is also a key factor that might help with the lower rates of vaccinated black immigrants.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Availability of Data and Material

Not applicable.

Code Availability

Not applicable.

References

  1. Bansal A, Singh MP, Rai B (2016) Human papillomavirus-associated cancers: a growing global problem. Int J Appl Basic Med Res 6(2):84–9. https://doi.org/10.4103/2229-516X.179027

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Serrano B, Brotons M, Bosch FX, Bruni L (2018) Epidemiology and burden of HPV-related disease. Best Pract Res Clin Obstet Gynaecol 47:14–26. https://doi.org/10.1016/j.bpobgyn.2017.08.006

    Article  PubMed  Google Scholar 

  3. Anderson M, López G (2018) Key facts about black immigrants in the U.S. https://www.pewresearch.org/fact-tank/2018/01/24/key-facts-about-black-immigrants-in-the-u-s/

  4. Senkomago V, Henley SJ, Thomas CC, Mix JM, Markowitz LE, Saraiya M (2019) Human papillomavirus-attributable cancers—United States, 2012–2016. MMWR Morb Mortal Wkly Rep 68(33):724–728

    Article  Google Scholar 

  5. Meites E, Szilagyi PG, Chesson HW, Unger ER, Romero JR, Markowitz LE (2019) Human papillomavirus vaccination for adults: updated recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep 68(32):698–702

    Article  Google Scholar 

  6. Walker TY, Elam-Evans LD, Yankey D et al (2019) National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years—United States, 2018. MMWR Morb Mortal Wkly Rep 68(33):718–723

    Article  Google Scholar 

  7. Lu P-j, Rodriguez-Lainz A, O’Halloran A, Greby S, Williams WW (2014) Adult vaccination disparities among foreign-born populations in the U.S. 2012. Am J Prev Med 47(6):722–733. https://doi.org/10.1016/j.amepre.2014.08.009

    Article  PubMed  PubMed Central  Google Scholar 

  8. Williams WW, Lu PJ, O’Halloran A et al (2017) Surveillance of vaccination coverage among adult populations—United States, 2015. MMWR Surveill Summ 66(11):1–28

    Article  Google Scholar 

  9. Pérez AE, Agénor M, Gamarel KE, Operario D (2018) Nativity disparities in human papillomavirus vaccination among U.S. adults. Am J Prev Med 54(2):248–258. https://doi.org/10.1016/j.amepre.2017.10.019

    Article  PubMed  Google Scholar 

  10. Bhattacharya M, Reiter PL, McRee AL (2019) Nativity status and genital HPV infection among adults in the U.S. Hum Vaccin Immunother 15(7–8):1897–1903. https://doi.org/10.1080/21645515.2019.1578592

    Article  PubMed  PubMed Central  Google Scholar 

  11. Amuta-Jimenez AO, Smith GPA, Brown KK (2020) Patterns and correlates of cervical cancer prevention among Black immigrant and African American women in the USA: the role of ethnicity and culture. J Cancer Educ. https://doi.org/10.1007/s13187-020-01884-1

    Article  PubMed  Google Scholar 

  12. Pinder LF, Nelson BD, Eckardt M, Goodman A (2016) A public health priority: disparities in gynecologic cancer research for African-Born Women in the United States. Clin Med Insights Womens Health 9:21–26. https://doi.org/10.4137/cmwh.s39867

    Article  PubMed  PubMed Central  Google Scholar 

  13. Guo F, Cofie LE, Berenson AB (2018) Cervical cancer incidence in young U.S. females after human papillomavirus vaccine introduction. Am J Prev Med. 55(2):197–204. https://doi.org/10.1016/j.amepre.2018.03.013

    Article  PubMed  PubMed Central  Google Scholar 

  14. Pinheiro PS, Callahan KE, Ragin C, Hage RW, Hylton T, Kobetz EN (2016) Black heterogeneity in cancer mortality: US-Blacks, Haitians, and Jamaicans. Cancer Control 23(4):347–358. https://doi.org/10.1177/107327481602300406

    Article  PubMed  Google Scholar 

  15. Adjei Boakye E, Zeng W, Governor S et al (2019) Differences in human papillomavirus (HPV) vaccine uptake by nativity status among men aged 18–34 years. Prev Med Rep 16:101010. https://doi.org/10.1016/j.pmedr.2019.101010

    Article  PubMed  PubMed Central  Google Scholar 

  16. Cofie LE, Hirth JM, Guo F, Berenson AB, Markides K, Wong R (2018) HPV vaccination among foreign-born women: examining the National Health Interview Survey 2013–2015. Am J Prev Med 54(1):20–27. https://doi.org/10.1016/j.amepre.2017.08.017

    Article  PubMed  Google Scholar 

  17. Centers for Disease Control National Center for Health Statistics (2019) National Health Interview Survey (NHIS): Questionnaires, datasets, and related documentation 2013–2015

  18. Centers for Disease Control National Center for Health Statistics. National Health Interview Survey (NHIS): Questionnaires, datasets, and related documentation 2013–2015

  19. Pisciotta MK (2012) Gendering gardasil: framing gender and sexuality in media representations of the HPV vaccine

  20. Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER (2007) Quadrivalent* human papillomavirus vaccine: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 56:1–24

    PubMed  Google Scholar 

  21. Sauer AG, Jemal A, Simard EP, Fedewa SA (2015) Differential uptake of recent Papanicolaou testing by HPV vaccination status among young women in the United States, 2008–2013. Cancer Epidemiol 39(4):650–655. https://doi.org/10.1016/j.canep.2015.05.002

    Article  PubMed  Google Scholar 

  22. Tiro JA, Tsui J, Bauer HM, Yamada E, Kobrin S, Breen N (2012) Human papillomavirus vaccine use among adolescent girls and young adult women: an analysis of the 2007 California Health Interview Survey. J Womens Health 21(6):656–665

    Article  Google Scholar 

  23. Advisory Committee on Immunization Practices (2016) Vaccines for Children Program—vaccines to prevent human papillomavirus

  24. Williams WW, Lu PJ, O’Halloran A et al (2016) Surveillance of vaccination coverage among adult populations—United States, 2014. MMWR Surveill Summ 65(1):1–36. https://doi.org/10.15585/mmwr.ss6501a1

    Article  PubMed  Google Scholar 

  25. Lekoane KMB, Kuupiel D, Mashamba-Thompson TP, Ginindza TG (2019) Evidence on the prevalence, incidence, mortality and trends of human papilloma virus-associated cancers in sub-Saharan Africa: systematic scoping review. BMC Cancer 19(1):563. https://doi.org/10.1186/s12885-019-5781-3

    Article  PubMed  PubMed Central  Google Scholar 

  26. Plummer M, de Martel C, Vignat J, Ferlay J, Bray F, Franceschi S (2016) Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health. 4(9):e609–e616. https://doi.org/10.1016/S2214-109X(16)30143-7

    Article  PubMed  Google Scholar 

  27. VanWormer JJ, Bendixsen CG, Vickers ER et al (2017) Association between parent attitudes and receipt of human papillomavirus vaccine in adolescents. BMC Public Health 17(1):766. https://doi.org/10.1186/s12889-017-4787-5

    Article  PubMed  PubMed Central  Google Scholar 

  28. Thompson E, Sofo S (2014) Maternal mortality in Ghana: an econometric analysis 3(2):115–124

    Google Scholar 

  29. De P, Budhwani H (2017) Human papillomavirus (HPV) vaccine initiation in minority Americans. Public Health 144:86–91. https://doi.org/10.1016/j.puhe.2016.11.005

    Article  CAS  PubMed  Google Scholar 

  30. Schmidt S, Parsons HM (2014) Vaccination interest and trends in human papillomavirus vaccine uptake in young adult women aged 18 to 26 years in the United States: an analysis using the 2008–2012 National Health Interview Survey. Am J Public Health 104(5):946–953. https://doi.org/10.2105/AJPH.2013.301828

    Article  PubMed  PubMed Central  Google Scholar 

  31. Adeyinka A, Pierre L (2020) Children's Health Insurance Program (CHIP). StatPearls. StatPearls Publishing Copyright © 2020, StatPearls Publishing LLC

  32. Durham DP, Ndeffo-Mbah ML, Skrip LA, Jones FK, Bauch CT, Galvani AP (2016) National- and state-level impact and cost-effectiveness of nonavalent HPV vaccination in the United States. Proc Natl Acad Sci U S A 113(18):5107–5112. https://doi.org/10.1073/pnas.1515528113

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Hirth J (2019) Disparities in HPV vaccination rates and HPV prevalence in the United States: a review of the literature. Hum Vaccin Immunother 15(1):146–155. https://doi.org/10.1080/21645515.2018.1512453

    Article  PubMed  Google Scholar 

  34. Daley EM, Vamos CA, Thompson EL et al (2017) The feminization of HPV: how science, politics, economics and gender norms shaped U.S. HPV vaccine implementation. Papillomavirus Res 3:142–148. https://doi.org/10.1016/j.pvr.2017.04.004

    Article  PubMed  PubMed Central  Google Scholar 

  35. Holman DM, Benard V, Roland KB, Watson M, Liddon N, Stokley S (2014) Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatr 168(1):76–82. https://doi.org/10.1001/jamapediatrics.2013.2752

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Leslie E. Cofie.

Ethics declarations

Conflict of interest

The authors have no conflict of interest to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cofie, L.E., Tailor, H.D., Lee, M.H. et al. HPV vaccination uptake among foreign-born Blacks in the US: insights from the National Health Interview Survey 2013–2017. Cancer Causes Control 33, 583–591 (2022). https://doi.org/10.1007/s10552-021-01550-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10552-021-01550-x

Keywords

Navigation